Silva, R. Et Al. 2013. The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration. OPHTHALMOLOGY , vol.120, no.1 , 130-139.

Silva, R., Axer-Siegel, R., Eldem, B., Guymer, R., Kirchhof, B., Papp, A., ... Seres, A.(2013). The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration. OPHTHALMOLOGY , vol.120, no.1, 130-139.

Silva, Rufino Et Al. "The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration," OPHTHALMOLOGY , vol.120, no.1, 130-139, 2013

Silva, Rufino Et Al. "The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration." OPHTHALMOLOGY , vol.120, no.1, pp.130-139, 2013

Silva, R. Et Al. (2013) . "The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration." OPHTHALMOLOGY , vol.120, no.1, pp.130-139.

@article{article, author={Rufino Silva Et Al. }, title={The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration}, journal={OPHTHALMOLOGY}, year=2013, pages={130-139} }